INDBInternet News Database 2.5 Updated just now · 293 sources Show or hide images Light or dark

Results for “Psoriatic Arthritis Trial Yahoo”

Health
1 source

Who is covering this

Google NewsCenter
Truth score 41
Centre 100%100%
Google NewsCenter

Column | Powerful new weight-loss drug may also ease knee pain, major study finds

Column | Powerful new weight-loss drug may also ease knee pain, major study finds The Washington Post Eli Lilly Says Taltz/Zepbound Combo Shows Long-Term Efficacy in Psoriatic Arthritis Trial Yahoo Retatrutide Improves Knee OA Pain,...

Lean: Center OpinionFactuality: HighCountry: United StatesFunding: Corporate
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Google News100%
Avg reliability75
Low-credibility share0%
Fact / opinion0/1
State media0%
More analysis
Truth score: 41 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 75 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedpagetodayCenter
Truth score 38
Centre 100%100%
MedpagetodayCenter

Two Biologics for Psoriatic Arthritis Square Off in Big Trial

(MedPage Today) -- ORLANDO -- A large head-to-head trial reported here that pitted bimekizumab (Bimzelx) against risankizumab (Skyrizi) as treatment for psoriatic arthritis (PsA) yielded a winner, albeit with a couple caveats. Arthritic...

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

Tildrakizumab is the third IL-23 inhibitor to be approved by the FDA for psoriatic arthritis.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 100Sensationalism: 0 Amplification: 0

How we score

Like
Business
1 source

Who is covering this

NewsCenter
Truth score 38
Centre 100%100%
NewsCenter

GLP-1 RAs Improve Patient-Reported Outcomes in Rheumatoid, Psoriatic Arthritis

GLP-1 RAs Improve Patient-Reported Outcomes in Rheumatoid, Psoriatic Arthritis Rheumatology Advisor

Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 100Sensationalism: 0 Amplification: 0

How we score

Like
Business
1 source

Who is covering this

NewsCenter
Truth score 38
Centre 100%100%
NewsCenter

Psoriasis Linked to Higher Cataract Risk After Phototherapy

Psoriasis Linked to Higher Cataract Risk After Phototherapy EMJ

Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Technology
1 source

Who is covering this

The HinduLeans left
Truth score 43
Left 100%100%
The HinduLeans left

Why psoriasis can sometimes be hard to diagnose and when you need to see a doctor

Psoriasis can often resemble other skin conditions, making it important to know the signs and seek medical help early when necessary

Lean: Leans left Fact-focusedFactuality: HighCountry: IndiaFunding: PrivateOwner: The Hindu Group
Full coverage
Coverage breakdown
Funding
Private100%
Countries
India100%
Media ownership
The Hindu Group100%
Avg reliability80
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 43 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 80 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

HellomagazineCenter
Truth score 38
Centre 100%100%
HellomagazineCenter

The 31p psoriasis cure: a dermatologist explains

Yesterday news hit that a budget friendly pill could help ease psoriasis, but is it too good to be true? We asked an expert for her opinion

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 100Sensationalism: 0 Amplification: 0

How we score

Like
Science
1 source
Truth score 34
No rated outlets yet
Breaking Science NewsNo political lean

Could Common Cooking-Oil Fat Be Fueling Psoriasis Itch?

Scientists have identified a receptor on sensory nerves that appears to detect a fatty-acid byproduct found at high levels in psoriasis skin, and blocking it eased itch and skin thickening in mice.

Lean: No political lean Fact-focusedCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability-
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 34 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: Not rated Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 6 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

The HinduLeans left
Truth score 43
Left 100%100%
The HinduLeans left

UK approves J&J's oral psoriasis pill

In all four studies, patients who took the drug saw better results after 16 weeks than those given a placebo, the regulator said

Lean: Leans left Fact-focusedFactuality: HighCountry: IndiaFunding: PrivateOwner: The Hindu Group
Full coverage
Coverage breakdown
Funding
Private100%
Countries
India100%
Media ownership
The Hindu Group100%
Avg reliability80
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 43 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 80 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

Daily MailCenter
Truth score 37
Centre 100%100%
Daily MailCenter

DR PHILIPPA KAYE: I've treated patients tortured by psoriasis for more than 20 years. Everyone plagued by itchy red skin patches should make these easy lifestyle tweaks...and why I'm convinced that weight loss - with or without jabs - is crucial

Some of Britain's top experts are now calling for weight loss to be considered part of routine treatment.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: DMGT
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
DMGT100%
Avg reliability63
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 63 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 16 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

Daily MailCenter
Truth score 37
Centre 100%100%
Daily MailCenter

The £1-a-day pill that could clear debilitating psoriasis - without causing side effects: It's already used to lower cholesterol... now scientists have discovered it could transform skin too

Scientists found pantethine, a nutrient that comes from vitamin B5, calmed the cells in the immune system that drive the itchy and painful skin condition.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: DMGT
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
DMGT100%
Avg reliability63
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 63 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like